Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
about
Diagnostic accuracy of left ventricular longitudinal function by speckle tracking echocardiography to predict significant coronary artery stenosis. A systematic reviewCardiac risk in the treatment of breast cancer: assessment and management.Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsEvaluation of Subclinical Left Ventricular Systolic Dysfunction in Chronic Asymptomatic Alcoholics by Speckle Tracking Echocardiography.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Cardiac complications of chemotherapy: role of imaging.Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.Echocardiography in the era of multimodality cardiovascular imaging.Imaging for cardiotoxicity in cancer patients.Comparison of two-dimensional strain analysis using vendor-independent and vendor-specific software in adult and pediatric patients.Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future DirectionsCancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumabMultimodality imaging in the evaluation of cardiovascular manifestations of malignancy.Trastuzumab-induced cardiac dysfunction: A 'dual-hit'Noninvasive assessment of myocardial mechanics of the left ventricle in rabbits using velocity vector imaging.Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.Evaluation of Right Ventricular Myocardial Mechanics Using Velocity Vector Imaging of Cardiac MRI Cine Images in Transposition of the Great Arteries Following Atrial and Arterial Switch Operations.Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged SwordCardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerCancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumabEarly detection and prediction of cardiotoxicity in chemotherapy-treated patientsDoes diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingCardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study.Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.Speckle-tracking echocardiography: a new technique for assessing myocardial function.Role of echocardiography in cancer care.Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge.Early detection of chemotherapy-related left ventricular dysfunction.Biological drugs: classic adverse effects and new clinical evidences.The role of 3D wall motion tracking in heart failure.Cardiac toxicity of anticancer agents.Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.Cardiotoxicity due to chemotherapy: role of cardiac imaging.Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
P2860
Q26800115-162FFADF-6EA4-4FBE-A538-9707398F5B6BQ28081385-3D6974A1-5D9D-4138-8138-3E4E203DF378Q28087776-6DF9FFFE-0A40-4763-B9BF-5A78608798A1Q30357404-4CD4D8DC-CBD6-4A65-98C8-C6882B0E7457Q30401812-376E8462-B99C-4C45-954B-920D50FADADFQ30415201-409DE4B3-C4FD-4683-B6B5-4D783FC10B82Q30427656-8C812A41-6C41-437F-976D-146838582EE2Q30446509-BD73FB54-3181-41FC-992B-13FDBE41D543Q30451962-962DDA87-3A57-4A98-B26C-40808E70D90BQ30475016-AC7C5285-2420-4A48-89CE-1A122A826E84Q33817028-9EFFF3AD-5091-4075-B008-EFC6B43687A1Q33907581-EE7F4285-6D60-41F4-81C2-E2892DCB235AQ34474264-0D950210-7365-414C-8C6D-EE62092BCE02Q34734814-FCCA3D48-942C-4C18-AF06-CF7461B4B30EQ35532125-960A9328-8CA5-4B41-AC21-D23F0595E11FQ35694308-305CCEA8-A6D5-43C5-BD29-4E7A1B21BE75Q35905883-52B7DAFB-490F-40AE-B9EC-006AEEA74EE7Q36679430-F870CD6B-532D-4B24-AF81-FBC116D44078Q36721511-2B9E434C-BD65-4500-995B-3A4199BA44CDQ36788268-987782A8-8255-42E6-999C-FE4484E198C0Q36887091-4B22FBC6-C958-475D-983D-BFC8BFAD3CDFQ36988278-D85FB2A9-EAB9-4799-A11D-CCE661A778E3Q36988282-A1B2C890-FEF1-4943-B32A-903951AEF4DBQ37116520-1C640521-CCC7-4117-BD04-45638C1AA4B3Q37213203-B1CFC840-2CED-41D2-9741-864B72F8C676Q37598919-1319BDBF-BA64-490E-8EBC-15E886FF20A2Q37648395-093DA203-F17C-465B-82EA-023E8D24ED6FQ37824795-C9B78688-5B20-410D-B0F0-A2A9D48633F4Q37874172-23150310-82F4-40A3-B0E5-89ED6ECD45D8Q37973320-CF2B366F-8A73-4F56-AA47-641815D1AB82Q37993439-4F9A302A-72D8-4A8F-BB3A-3F1DE6CFB6A3Q38015746-0E175F15-00E5-411D-AF9D-215FDB2D81E4Q38040308-4AEDA32A-C194-4935-8BD9-4BBD6496CD39Q38091377-C59295F5-BA92-48E2-8449-1DAC1E946265Q38197733-53C54FA0-187B-412E-A7B4-745868449D37Q38222800-33923657-859A-40B1-89C7-7E5A623E4CFFQ38343043-A4B5AC93-B80B-4063-9071-9DBA4B80F8ADQ38551776-C768AD43-A472-43E9-9432-6EDC7631A1FEQ38559474-151D1872-CFC7-4D89-9755-4DB0FFB3634EQ38773470-7C3B174F-5DBA-4D8A-9B9A-877891F774E7
P2860
Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Use of myocardial deformation ...... er treatment with trastuzumab.
@en
Use of myocardial deformation ...... er treatment with trastuzumab.
@nl
type
label
Use of myocardial deformation ...... er treatment with trastuzumab.
@en
Use of myocardial deformation ...... er treatment with trastuzumab.
@nl
prefLabel
Use of myocardial deformation ...... er treatment with trastuzumab.
@en
Use of myocardial deformation ...... er treatment with trastuzumab.
@nl
P2093
P1476
Use of myocardial deformation ...... cer treatment with trastuzumab
@en
P2093
James L Hare
Joseph K Brown
Rodel Leano
Thomas H Marwick
P304
P356
10.1016/J.AHJ.2009.05.031
P407
P577
2009-08-01T00:00:00Z